* Definitive Healthcare Corp DH.OQ DH.O is expected
to show a
rise in quarterly revenue when it reports results on November
3.
* The Framingham Massachusetts-based company is expected to
report a 31.5% increase in revenue to $56.645 million from
$43.08 million a year ago, according to the mean estimate from
10 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Definitive
Healthcare
Corp is for earnings of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Definitive
Healthcare Corp is $26, above its last closing price
of $15.66.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.05 0.05 0.06 Beat 18.3
Mar. 31 2022 0.03 0.03 0.05 Beat 44.9
Dec. 31 2021 0.04 0.04 0.04 Met -7.4
Sep. 30 2021 0.02 0.02 0.01 Missed -47.4
This summary was machine generated November 2 at 02:05 GMT. All
figures in US dollars unless otherwise stated